HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trialYan Song, Jing Huang, Shu Zhang et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 20
Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 studyBo Zhang, Jing Huang, Yan Song et al.|Cell Reports Medicine|2023Cited by 6